Interestingly, gating within the CD11b+CD45+ cells, we found that the CD206+ population cells (alternatively activated beneficial myeloid cells) were significantly increased in the 5 days post-stroke ChP compared to the sham control (Figures 6C, D, p < 0.05). This evidence concerns the gene PTPRC and Stroke.